

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 4.96780441 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.80068695 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.80068695 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.63693936 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.41169280 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.41016462 |
| 7 | glutamate secretion (GO:0014047) | 4.25532909 |
| 8 | glycosphingolipid catabolic process (GO:0046479) | 4.11034207 |
| 9 | vocalization behavior (GO:0071625) | 4.06696028 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.03915244 |
| 11 | protein retention in ER lumen (GO:0006621) | 3.95620531 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.95300937 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92277879 |
| 14 | locomotory exploration behavior (GO:0035641) | 3.91724505 |
| 15 | transferrin transport (GO:0033572) | 3.89978630 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.84239636 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 3.83281007 |
| 18 | neuronal action potential propagation (GO:0019227) | 3.82996135 |
| 19 | amyloid precursor protein catabolic process (GO:0042987) | 3.82116513 |
| 20 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.81900596 |
| 21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.81791439 |
| 22 | barbed-end actin filament capping (GO:0051016) | 3.78461291 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.76600276 |
| 24 | glycolipid catabolic process (GO:0019377) | 3.68562130 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.68503728 |
| 26 | protein localization to endosome (GO:0036010) | 3.68004090 |
| 27 | ferric iron transport (GO:0015682) | 3.66571595 |
| 28 | trivalent inorganic cation transport (GO:0072512) | 3.66571595 |
| 29 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.62927979 |
| 30 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.61498791 |
| 31 | neurotransmitter secretion (GO:0007269) | 3.60382173 |
| 32 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.58044736 |
| 33 | * ATP hydrolysis coupled proton transport (GO:0015991) | 3.58044736 |
| 34 | amino sugar catabolic process (GO:0046348) | 3.48027924 |
| 35 | protein localization to synapse (GO:0035418) | 3.44920425 |
| 36 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.43941786 |
| 37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.41365097 |
| 38 | glucose 6-phosphate metabolic process (GO:0051156) | 3.38996589 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.38499569 |
| 40 | cellular potassium ion homeostasis (GO:0030007) | 3.37927446 |
| 41 | proline transport (GO:0015824) | 3.36647927 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34853997 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.32379756 |
| 44 | phagosome maturation (GO:0090382) | 3.29762720 |
| 45 | protein maturation by protein folding (GO:0022417) | 3.28900638 |
| 46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.25758641 |
| 47 | neuron-neuron synaptic transmission (GO:0007270) | 3.22846257 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.19849720 |
| 49 | oligosaccharide catabolic process (GO:0009313) | 3.18437114 |
| 50 | ceramide catabolic process (GO:0046514) | 3.17068010 |
| 51 | mannose metabolic process (GO:0006013) | 3.15944527 |
| 52 | exploration behavior (GO:0035640) | 3.15385618 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 3.14169838 |
| 54 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.13093521 |
| 55 | glutamate receptor signaling pathway (GO:0007215) | 3.10916564 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 3.07586109 |
| 57 | presynaptic membrane organization (GO:0097090) | 3.06456608 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.03966104 |
| 59 | neurotransmitter transport (GO:0006836) | 2.99787994 |
| 60 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.99075909 |
| 61 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96757912 |
| 62 | activation of protein kinase A activity (GO:0034199) | 2.95030066 |
| 63 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.94748763 |
| 64 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.93732902 |
| 65 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.93122752 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.91054624 |
| 67 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90781275 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.89338466 |
| 69 | postsynaptic membrane organization (GO:0001941) | 2.84971223 |
| 70 | response to peptidoglycan (GO:0032494) | 2.84428122 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83991091 |
| 72 | neuromuscular process controlling posture (GO:0050884) | 2.82975471 |
| 73 | regulation of cholesterol storage (GO:0010885) | 2.80874436 |
| 74 | cerebellar granule cell differentiation (GO:0021707) | 2.80386078 |
| 75 | neuron recognition (GO:0008038) | 2.78831944 |
| 76 | regulation of neurotransmitter secretion (GO:0046928) | 2.78501566 |
| 77 | amyloid precursor protein metabolic process (GO:0042982) | 2.78435624 |
| 78 | response to thyroid hormone (GO:0097066) | 2.78191340 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 2.77216346 |
| 80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.73823525 |
| 81 | regulation of postsynaptic membrane potential (GO:0060078) | 2.73643255 |
| 82 | regulation of neurotransmitter levels (GO:0001505) | 2.73246518 |
| 83 | regulation of defense response to virus by virus (GO:0050690) | 2.71277348 |
| 84 | sphingolipid catabolic process (GO:0030149) | 2.70886065 |
| 85 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.70261199 |
| 86 | regulation of vesicle fusion (GO:0031338) | 2.70086321 |
| 87 | positive regulation of synapse maturation (GO:0090129) | 2.69345264 |
| 88 | membrane lipid catabolic process (GO:0046466) | 2.68976708 |
| 89 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.68787184 |
| 90 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.68349276 |
| 91 | synaptic vesicle endocytosis (GO:0048488) | 2.67875548 |
| 92 | positive regulation of membrane potential (GO:0045838) | 2.67163054 |
| 93 | N-acetylneuraminate metabolic process (GO:0006054) | 2.66898884 |
| 94 | long-term memory (GO:0007616) | 2.66737964 |
| 95 | establishment of synaptic vesicle localization (GO:0097480) | 2.65416019 |
| 96 | synaptic vesicle transport (GO:0048489) | 2.65416019 |
| 97 | sodium ion export (GO:0071436) | 2.64428092 |
| 98 | detection of calcium ion (GO:0005513) | 2.64217457 |
| 99 | cellular copper ion homeostasis (GO:0006878) | 2.63674378 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 2.62899659 |
| 101 | serine transport (GO:0032329) | 2.62820344 |
| 102 | positive regulation of synaptic transmission (GO:0050806) | 2.62761106 |
| 103 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.62672683 |
| 104 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.62212865 |
| 105 | vesicle transport along microtubule (GO:0047496) | 2.61103709 |
| 106 | cerebellar Purkinje cell layer development (GO:0021680) | 2.60925710 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 2.59352347 |
| 108 | negative regulation of cell size (GO:0045792) | 2.59137854 |
| 109 | response to histamine (GO:0034776) | 2.58751223 |
| 110 | cell-cell junction maintenance (GO:0045217) | 2.57961524 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.57129811 |
| 112 | negative regulation of neurotransmitter transport (GO:0051589) | 2.57057075 |
| 113 | semaphorin-plexin signaling pathway (GO:0071526) | 2.55038155 |
| 114 | regulation of early endosome to late endosome transport (GO:2000641) | 2.55001914 |
| 115 | regulation of beta-amyloid formation (GO:1902003) | 2.52028513 |
| 116 | regulation of regulated secretory pathway (GO:1903305) | 2.51873675 |
| 117 | pentose-phosphate shunt (GO:0006098) | 2.50697747 |
| 118 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.50582902 |
| 119 | apoptotic cell clearance (GO:0043277) | 2.49578018 |
| 120 | synaptic transmission (GO:0007268) | 2.49109367 |
| 121 | potassium ion import (GO:0010107) | 2.47740282 |
| 122 | regulation of synaptic transmission (GO:0050804) | 2.47624594 |
| 123 | startle response (GO:0001964) | 2.46331008 |
| 124 | membrane depolarization (GO:0051899) | 2.46091967 |
| 125 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.46032738 |
| 126 | positive regulation of neurotransmitter transport (GO:0051590) | 2.45980430 |
| 127 | clathrin coat assembly (GO:0048268) | 2.45951684 |
| 128 | mating behavior (GO:0007617) | 2.44735900 |
| 129 | ganglioside metabolic process (GO:0001573) | 2.43612884 |
| 130 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.43560781 |
| 131 | layer formation in cerebral cortex (GO:0021819) | 2.43466211 |
| 132 | protein insertion into membrane (GO:0051205) | 2.43436554 |
| 133 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.43203801 |
| 134 | axonal fasciculation (GO:0007413) | 2.42565815 |
| 135 | regulation of autophagic vacuole assembly (GO:2000785) | 2.42407664 |
| 136 | iron ion transport (GO:0006826) | 2.41840206 |
| 137 | establishment of vesicle localization (GO:0051650) | 2.41278823 |
| 138 | synapse assembly (GO:0007416) | 2.41160014 |
| 139 | acidic amino acid transport (GO:0015800) | 2.40774606 |
| 140 | response to auditory stimulus (GO:0010996) | 2.40347008 |
| 141 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.40187488 |
| 142 | glycine transport (GO:0015816) | 2.39788570 |
| 143 | adult walking behavior (GO:0007628) | 2.39752548 |
| 144 | * regulation of exocytosis (GO:0017157) | 2.39401521 |
| 145 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.37153948 |
| 146 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.37122503 |
| 147 | response to acidic pH (GO:0010447) | 2.34023198 |
| 148 | positive regulation of leukocyte degranulation (GO:0043302) | 2.33455469 |
| 149 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.33100213 |
| 150 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.32535647 |
| 151 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.31867179 |
| 152 | regulation of superoxide anion generation (GO:0032928) | 2.30595212 |
| 153 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29905151 |
| 154 | L-serine transport (GO:0015825) | 2.28272427 |
| 155 | glucose catabolic process (GO:0006007) | 2.25821270 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 2.25283078 |
| 157 | lysosome organization (GO:0007040) | 2.24623533 |
| 158 | lytic vacuole organization (GO:0080171) | 2.24623533 |
| 159 | regulation of ARF protein signal transduction (GO:0032012) | 2.24393047 |
| 160 | regulation of vacuole organization (GO:0044088) | 2.23667467 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.23160232 |
| 162 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.22741841 |
| 163 | positive regulation of regulated secretory pathway (GO:1903307) | 2.21732000 |
| 164 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.21639430 |
| 165 | positive regulation of protein dephosphorylation (GO:0035307) | 2.21584463 |
| 166 | adenosine receptor signaling pathway (GO:0001973) | 2.21215723 |
| 167 | stress fiber assembly (GO:0043149) | 2.19116815 |
| 168 | positive regulation of receptor recycling (GO:0001921) | 2.13991423 |
| 169 | hyaluronan catabolic process (GO:0030214) | 2.13712316 |
| 170 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.13650196 |
| 171 | decidualization (GO:0046697) | 2.12591681 |
| 172 | negative regulation of microtubule polymerization (GO:0031115) | 2.12527354 |
| 173 | positive regulation of nuclease activity (GO:0032075) | 2.12276098 |
| 174 | adhesion of symbiont to host (GO:0044406) | 2.12121879 |
| 175 | vesicle coating (GO:0006901) | 2.11538821 |
| 176 | pinocytosis (GO:0006907) | 2.11373125 |
| 177 | neutrophil activation involved in immune response (GO:0002283) | 2.11226518 |
| 178 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.11224712 |
| 179 | alpha-linolenic acid metabolic process (GO:0036109) | 2.11008430 |
| 180 | amino acid import (GO:0043090) | 2.10679750 |
| 181 | glial cell migration (GO:0008347) | 2.10590492 |
| 182 | oligosaccharide metabolic process (GO:0009311) | 2.09741148 |
| 183 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.09199929 |
| 184 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.08290044 |
| 185 | virion assembly (GO:0019068) | 2.07821299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.16379122 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.87542869 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.19423181 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05717297 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98512250 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.97542591 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.91374288 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.89406404 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58033333 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.55154623 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47998919 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46379670 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44326668 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42826151 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.36722468 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.36722468 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.32452885 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31124631 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.26241748 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.21751165 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20826098 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.20116682 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.15382036 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12677246 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11208063 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10235707 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09868359 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09429964 |
| 29 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.09324431 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.08145378 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.06613286 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.06207478 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.04520351 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97621593 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97536599 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90112462 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88811415 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.87039403 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82060956 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79567918 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78535843 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.77779582 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.75224477 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73493938 |
| 45 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71951551 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.71315096 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69064613 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68287764 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67762597 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66734948 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66231680 |
| 52 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.65115634 |
| 53 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.64331626 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63011754 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.62796508 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60835251 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.59221301 |
| 58 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.58962173 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58814351 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54834922 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.53935238 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52492245 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51544321 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51372913 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49693373 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47772958 |
| 67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46787212 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45824742 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45761829 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44364174 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42881373 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42681730 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42345351 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42054640 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41869295 |
| 76 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41196717 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38484677 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37148314 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34421497 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33805273 |
| 81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32476555 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32352096 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32301253 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32183483 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32181621 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32180934 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32155343 |
| 88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30394207 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30312395 |
| 90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29641453 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28470362 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28039844 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27656260 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27639540 |
| 95 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27568541 |
| 96 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26900063 |
| 97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26541585 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26251809 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24159994 |
| 100 | MYC_22102868_ChIP-Seq_BL_Human | 1.23296159 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23021348 |
| 102 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22845650 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21637339 |
| 104 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21559288 |
| 105 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21114224 |
| 106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20778361 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20097553 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19963821 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19963821 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19202328 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16316695 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15715533 |
| 113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15692203 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15553350 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15286325 |
| 116 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15255439 |
| 117 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.15017311 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13935087 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13560410 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12698158 |
| 121 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11920805 |
| 122 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11043034 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10994326 |
| 124 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10735330 |
| 125 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09903689 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09612608 |
| 127 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09521574 |
| 128 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09078360 |
| 129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09066366 |
| 130 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09007161 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08986860 |
| 132 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08950092 |
| 133 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08297464 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07492293 |
| 135 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06480845 |
| 136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06012720 |
| 137 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05979663 |
| 138 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05792580 |
| 139 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05525756 |
| 140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05445712 |
| 141 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05371490 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04959897 |
| 143 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04937531 |
| 144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04652418 |
| 145 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04402613 |
| 146 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04199559 |
| 147 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03874543 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03039316 |
| 149 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02883967 |
| 150 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02852684 |
| 151 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02743443 |
| 152 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02612819 |
| 153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02534321 |
| 154 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02499454 |
| 155 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02469988 |
| 156 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02362130 |
| 157 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01959715 |
| 158 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01506654 |
| 159 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.01152131 |
| 160 | AR_19668381_ChIP-Seq_PC3_Human | 1.00967568 |
| 161 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00450266 |
| 162 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00387564 |
| 163 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00057888 |
| 164 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99727629 |
| 165 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99363900 |
| 166 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99280907 |
| 167 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97437302 |
| 168 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94557697 |
| 169 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94500903 |
| 170 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93982604 |
| 171 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92621931 |
| 172 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92002408 |
| 173 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90548123 |
| 174 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90283472 |
| 175 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89621157 |
| 176 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89465527 |
| 177 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88998387 |
| 178 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88963206 |
| 179 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87960871 |
| 180 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87910988 |
| 181 | JUN_21703547_ChIP-Seq_K562_Human | 0.87233514 |
| 182 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86340124 |
| 183 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86204969 |
| 184 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84386430 |
| 185 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.81881367 |
| 186 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81801238 |
| 187 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80700311 |
| 188 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79841213 |
| 189 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.79609892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.98215621 |
| 2 | MP0003880_abnormal_central_pattern | 4.10929823 |
| 3 | MP0009840_abnormal_foam_cell | 4.02295255 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.54509821 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.50694030 |
| 6 | MP0002064_seizures | 3.18078967 |
| 7 | MP0009046_muscle_twitch | 3.09668699 |
| 8 | MP0004270_analgesia | 3.08386586 |
| 9 | MP0009745_abnormal_behavioral_response | 2.98398762 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.79038062 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.78721109 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.71827503 |
| 13 | MP0005451_abnormal_body_composition | 2.61383217 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.51903054 |
| 15 | MP0002736_abnormal_nociception_after | 2.49189234 |
| 16 | MP0002272_abnormal_nervous_system | 2.43981606 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.42364017 |
| 18 | MP0003329_amyloid_beta_deposits | 2.39750988 |
| 19 | MP0003436_decreased_susceptibility_to | 2.34341428 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.32825292 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.28228336 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.17126319 |
| 23 | MP0009278_abnormal_bone_marrow | 2.12761697 |
| 24 | MP0006082_CNS_inflammation | 2.04864482 |
| 25 | MP0000013_abnormal_adipose_tissue | 2.02961089 |
| 26 | MP0002909_abnormal_adrenal_gland | 2.02083284 |
| 27 | MP0001486_abnormal_startle_reflex | 2.01714305 |
| 28 | MP0001970_abnormal_pain_threshold | 2.01102651 |
| 29 | MP0002733_abnormal_thermal_nociception | 2.00876658 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.93122378 |
| 31 | MP0002822_catalepsy | 1.91897291 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.87125232 |
| 33 | MP0000343_altered_response_to | 1.86643184 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.84743151 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.83994349 |
| 36 | MP0004858_abnormal_nervous_system | 1.80915258 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.79830467 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.77542875 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.71533179 |
| 40 | MP0003879_abnormal_hair_cell | 1.67076408 |
| 41 | MP0008569_lethality_at_weaning | 1.63656637 |
| 42 | MP0000604_amyloidosis | 1.62799018 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.61744857 |
| 44 | MP0002419_abnormal_innate_immunity | 1.60273053 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.57176592 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.55169395 |
| 47 | MP0001849_ear_inflammation | 1.52323720 |
| 48 | MP0004043_abnormal_pH_regulation | 1.50122684 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.49788825 |
| 50 | MP0000920_abnormal_myelination | 1.49233828 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.46680392 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.46627263 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.46153238 |
| 54 | MP0004924_abnormal_behavior | 1.46153238 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.45593971 |
| 56 | MP0001529_abnormal_vocalization | 1.45296777 |
| 57 | MP0003690_abnormal_glial_cell | 1.44774697 |
| 58 | MP0002184_abnormal_innervation | 1.43220370 |
| 59 | MP0001984_abnormal_olfaction | 1.42963657 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.41960785 |
| 61 | MP0003633_abnormal_nervous_system | 1.41929608 |
| 62 | MP0001905_abnormal_dopamine_level | 1.39553392 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.36853325 |
| 64 | MP0003634_abnormal_glial_cell | 1.36315433 |
| 65 | MP0005025_abnormal_response_to | 1.34332469 |
| 66 | MP0003724_increased_susceptibility_to | 1.33811182 |
| 67 | MP0002557_abnormal_social/conspecific_i | 1.32728532 |
| 68 | MP0005257_abnormal_intraocular_pressure | 1.29792393 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.27816458 |
| 70 | MP0002090_abnormal_vision | 1.26575881 |
| 71 | MP0004142_abnormal_muscle_tone | 1.26516829 |
| 72 | MP0000858_altered_metastatic_potential | 1.26377556 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.26339979 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.25465235 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.25428150 |
| 76 | MP0000955_abnormal_spinal_cord | 1.23409080 |
| 77 | MP0003122_maternal_imprinting | 1.21518981 |
| 78 | MP0000778_abnormal_nervous_system | 1.19992961 |
| 79 | MP0002882_abnormal_neuron_morphology | 1.18053900 |
| 80 | MP0003631_nervous_system_phenotype | 1.16963656 |
| 81 | MP0004947_skin_inflammation | 1.16050294 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 1.15677985 |
| 83 | MP0004885_abnormal_endolymph | 1.12629887 |
| 84 | MP0002229_neurodegeneration | 1.11858183 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.09710417 |
| 86 | MP0005000_abnormal_immune_tolerance | 1.09299840 |
| 87 | MP0001502_abnormal_circadian_rhythm | 1.08714682 |
| 88 | MP0009785_altered_susceptibility_to | 1.07609529 |
| 89 | MP0003075_altered_response_to | 1.05703020 |
| 90 | MP0002139_abnormal_hepatobiliary_system | 1.05355740 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 1.04918805 |
| 92 | MP0005166_decreased_susceptibility_to | 1.04089317 |
| 93 | MP0005165_increased_susceptibility_to | 1.03987074 |
| 94 | MP0003279_aneurysm | 1.03556313 |
| 95 | MP0000751_myopathy | 1.03427304 |
| 96 | MP0001545_abnormal_hematopoietic_system | 1.03297943 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 1.03297943 |
| 98 | MP0008438_abnormal_cutaneous_collagen | 1.03266258 |
| 99 | MP0002653_abnormal_ependyma_morphology | 1.00145104 |
| 100 | MP0003195_calcinosis | 0.99619161 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.98593254 |
| 102 | MP0003787_abnormal_imprinting | 0.94671181 |
| 103 | MP0005171_absent_coat_pigmentation | 0.94014823 |
| 104 | MP0003632_abnormal_nervous_system | 0.93110375 |
| 105 | MP0000678_abnormal_parathyroid_gland | 0.93009051 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.92046075 |
| 107 | MP0005409_darkened_coat_color | 0.90517673 |
| 108 | MP0005535_abnormal_body_temperature | 0.84570273 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.84380599 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.83515020 |
| 111 | MP0004742_abnormal_vestibular_system | 0.83443624 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.83345643 |
| 113 | MP0008874_decreased_physiological_sensi | 0.83095142 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.81610905 |
| 115 | MP0001542_abnormal_bone_strength | 0.80916214 |
| 116 | MP0008469_abnormal_protein_level | 0.80106308 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.79290393 |
| 118 | MP0005310_abnormal_salivary_gland | 0.77663278 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.77144358 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.76746942 |
| 121 | MP0001853_heart_inflammation | 0.76091327 |
| 122 | MP0002796_impaired_skin_barrier | 0.75016334 |
| 123 | MP0001664_abnormal_digestion | 0.74867192 |
| 124 | MP0003303_peritoneal_inflammation | 0.74370173 |
| 125 | MP0004085_abnormal_heartbeat | 0.73654215 |
| 126 | MP0005387_immune_system_phenotype | 0.73289032 |
| 127 | MP0001790_abnormal_immune_system | 0.73289032 |
| 128 | MP0004484_altered_response_of | 0.73166890 |
| 129 | MP0001963_abnormal_hearing_physiology | 0.71919995 |
| 130 | MP0005390_skeleton_phenotype | 0.71837880 |
| 131 | MP0004233_abnormal_muscle_weight | 0.71703587 |
| 132 | MP0003123_paternal_imprinting | 0.71662805 |
| 133 | MP0002452_abnormal_antigen_presenting | 0.71125570 |
| 134 | MP0002152_abnormal_brain_morphology | 0.71056236 |
| 135 | MP0004130_abnormal_muscle_cell | 0.70694873 |
| 136 | MP0009764_decreased_sensitivity_to | 0.70380004 |
| 137 | MP0003091_abnormal_cell_migration | 0.70249132 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.69587216 |
| 139 | MP0005671_abnormal_response_to | 0.69084489 |
| 140 | MP0003795_abnormal_bone_structure | 0.68110650 |
| 141 | MP0005365_abnormal_bile_salt | 0.68036258 |
| 142 | MP0008004_abnormal_stomach_pH | 0.67600673 |
| 143 | MP0009333_abnormal_splenocyte_physiolog | 0.67460046 |
| 144 | MP0004264_abnormal_extraembryonic_tissu | 0.67051823 |
| 145 | MP0002723_abnormal_immune_serum | 0.66876364 |
| 146 | MP0001727_abnormal_embryo_implantation | 0.65937153 |
| 147 | MP0005623_abnormal_meninges_morphology | 0.65856563 |
| 148 | MP0000747_muscle_weakness | 0.64650204 |
| 149 | MP0001177_atelectasis | 0.63707899 |
| 150 | MP0010155_abnormal_intestine_physiology | 0.63027427 |
| 151 | MP0003283_abnormal_digestive_organ | 0.62660355 |
| 152 | MP0003045_fibrosis | 0.62436569 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.61513679 |
| 154 | MP0004145_abnormal_muscle_electrophysio | 0.61130993 |
| 155 | MP0004036_abnormal_muscle_relaxation | 0.60978078 |
| 156 | MP0004215_abnormal_myocardial_fiber | 0.60692238 |
| 157 | MP0000003_abnormal_adipose_tissue | 0.60449588 |
| 158 | MP0001986_abnormal_taste_sensitivity | 0.59325546 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.59308940 |
| 160 | MP0004510_myositis | 0.59305629 |
| 161 | MP0001188_hyperpigmentation | 0.57678229 |
| 162 | MP0008260_abnormal_autophagy | 0.55233558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.14117985 |
| 2 | Atonic seizures (HP:0010819) | 4.72006103 |
| 3 | Visual hallucinations (HP:0002367) | 4.53718948 |
| 4 | Focal seizures (HP:0007359) | 4.38197746 |
| 5 | Myokymia (HP:0002411) | 4.34281596 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.22726068 |
| 7 | Absence seizures (HP:0002121) | 3.75236991 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.74303124 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.73247342 |
| 10 | J-shaped sella turcica (HP:0002680) | 3.71804723 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.67717215 |
| 12 | Pheochromocytoma (HP:0002666) | 3.60574803 |
| 13 | Dialeptic seizures (HP:0011146) | 3.55790976 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 3.39574407 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.33812898 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.32091690 |
| 17 | Diminished motivation (HP:0000745) | 3.26866352 |
| 18 | Febrile seizures (HP:0002373) | 3.24691580 |
| 19 | Neuroendocrine neoplasm (HP:0100634) | 3.23555463 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.15771694 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.12090141 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.04796485 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 2.98186265 |
| 24 | Axonal loss (HP:0003447) | 2.97957972 |
| 25 | Dysostosis multiplex (HP:0000943) | 2.94997847 |
| 26 | Polyphagia (HP:0002591) | 2.94794881 |
| 27 | Mutism (HP:0002300) | 2.94689449 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.94256026 |
| 29 | Hyperventilation (HP:0002883) | 2.93856323 |
| 30 | Action tremor (HP:0002345) | 2.92816049 |
| 31 | Nuclear cataract (HP:0100018) | 2.91997032 |
| 32 | Diplopia (HP:0000651) | 2.86458726 |
| 33 | Abnormality of binocular vision (HP:0011514) | 2.86458726 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.77846255 |
| 35 | Hand muscle atrophy (HP:0009130) | 2.77628571 |
| 36 | Upper limb amyotrophy (HP:0009129) | 2.76284769 |
| 37 | Distal upper limb amyotrophy (HP:0007149) | 2.76284769 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.76217751 |
| 39 | Depression (HP:0000716) | 2.71260053 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.70644212 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.70644212 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.70644212 |
| 43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.61406400 |
| 44 | Ankle clonus (HP:0011448) | 2.60694046 |
| 45 | Truncal ataxia (HP:0002078) | 2.58008779 |
| 46 | Anxiety (HP:0000739) | 2.55933029 |
| 47 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.55010296 |
| 48 | Progressive neurologic deterioration (HP:0002344) | 2.53987707 |
| 49 | Failure to thrive in infancy (HP:0001531) | 2.51693798 |
| 50 | Progressive inability to walk (HP:0002505) | 2.46588127 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.43382867 |
| 52 | Dysmetria (HP:0001310) | 2.40918296 |
| 53 | Cholecystitis (HP:0001082) | 2.38956176 |
| 54 | Abnormal gallbladder physiology (HP:0012438) | 2.38956176 |
| 55 | Purpura (HP:0000979) | 2.38386092 |
| 56 | Prolonged neonatal jaundice (HP:0006579) | 2.37335286 |
| 57 | Hyperparathyroidism (HP:0000843) | 2.36279068 |
| 58 | Agitation (HP:0000713) | 2.36101188 |
| 59 | Broad-based gait (HP:0002136) | 2.35490703 |
| 60 | Dysdiadochokinesis (HP:0002075) | 2.33589573 |
| 61 | Akinesia (HP:0002304) | 2.31702012 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.31375374 |
| 63 | Insidious onset (HP:0003587) | 2.30704289 |
| 64 | Termporal pattern (HP:0011008) | 2.30704289 |
| 65 | Amyloidosis (HP:0011034) | 2.28979263 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.28341521 |
| 67 | Poor eye contact (HP:0000817) | 2.27769947 |
| 68 | Resting tremor (HP:0002322) | 2.27274810 |
| 69 | Dementia (HP:0000726) | 2.26611600 |
| 70 | Abnormal hair whorl (HP:0010721) | 2.26304297 |
| 71 | Disinhibition (HP:0000734) | 2.21693651 |
| 72 | Abnormal social behavior (HP:0012433) | 2.19847888 |
| 73 | Impaired social interactions (HP:0000735) | 2.19847888 |
| 74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19204344 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.19204344 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.18750644 |
| 77 | Cerebral aneurysm (HP:0004944) | 2.18625020 |
| 78 | Papilledema (HP:0001085) | 2.16859202 |
| 79 | Postural instability (HP:0002172) | 2.15817540 |
| 80 | Hypsarrhythmia (HP:0002521) | 2.15519359 |
| 81 | Spastic gait (HP:0002064) | 2.13906066 |
| 82 | Limb dystonia (HP:0002451) | 2.13166071 |
| 83 | Torticollis (HP:0000473) | 2.09753924 |
| 84 | Generalized myoclonic seizures (HP:0002123) | 2.09207529 |
| 85 | Hyperacusis (HP:0010780) | 2.09178390 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09123239 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09123239 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09123239 |
| 89 | Recurrent abscess formation (HP:0002722) | 2.08492007 |
| 90 | Psychosis (HP:0000709) | 2.08255900 |
| 91 | Intention tremor (HP:0002080) | 2.08119871 |
| 92 | Oligomenorrhea (HP:0000876) | 2.07504386 |
| 93 | Gaze-evoked nystagmus (HP:0000640) | 2.06195005 |
| 94 | Deformed sella turcica (HP:0002681) | 2.06094589 |
| 95 | Distal lower limb muscle weakness (HP:0009053) | 2.05713739 |
| 96 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.05654198 |
| 97 | Abnormality of the corticospinal tract (HP:0002492) | 2.05261407 |
| 98 | Amblyopia (HP:0000646) | 2.03732424 |
| 99 | Postural tremor (HP:0002174) | 2.02493713 |
| 100 | Cardiomegaly (HP:0001640) | 2.01763607 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.01666339 |
| 102 | Scanning speech (HP:0002168) | 2.00956410 |
| 103 | Excessive salivation (HP:0003781) | 2.00272060 |
| 104 | Drooling (HP:0002307) | 2.00272060 |
| 105 | Clumsiness (HP:0002312) | 1.99501630 |
| 106 | Achilles tendon contracture (HP:0001771) | 1.99467984 |
| 107 | Rapidly progressive (HP:0003678) | 1.98709103 |
| 108 | Hypokinesia (HP:0002375) | 1.98543933 |
| 109 | Retinal atrophy (HP:0001105) | 1.96677314 |
| 110 | Abnormality of the periventricular white matter (HP:0002518) | 1.96486129 |
| 111 | Cervical subluxation (HP:0003308) | 1.95688137 |
| 112 | Hypoventilation (HP:0002791) | 1.94894234 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.94837717 |
| 114 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.94837717 |
| 115 | Bradykinesia (HP:0002067) | 1.93717444 |
| 116 | Growth hormone excess (HP:0000845) | 1.92454152 |
| 117 | Pathologic fracture (HP:0002756) | 1.92038485 |
| 118 | Upper motor neuron abnormality (HP:0002127) | 1.92012180 |
| 119 | Focal dystonia (HP:0004373) | 1.91838859 |
| 120 | Gait imbalance (HP:0002141) | 1.91501207 |
| 121 | Asymmetric septal hypertrophy (HP:0001670) | 1.91439993 |
| 122 | Personality changes (HP:0000751) | 1.91403780 |
| 123 | Rigidity (HP:0002063) | 1.91074636 |
| 124 | Recurrent bacterial skin infections (HP:0005406) | 1.90261229 |
| 125 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.89510038 |
| 126 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.88949002 |
| 127 | Increased serum ferritin (HP:0003281) | 1.88362850 |
| 128 | Retinal dysplasia (HP:0007973) | 1.85869708 |
| 129 | Vacuolated lymphocytes (HP:0001922) | 1.84146192 |
| 130 | Thin bony cortex (HP:0002753) | 1.83362116 |
| 131 | Hypercortisolism (HP:0001578) | 1.82735478 |
| 132 | Inability to walk (HP:0002540) | 1.81937322 |
| 133 | Glomerulonephritis (HP:0000099) | 1.81926764 |
| 134 | Poor suck (HP:0002033) | 1.81861096 |
| 135 | Gait ataxia (HP:0002066) | 1.81109255 |
| 136 | Ragged-red muscle fibers (HP:0003200) | 1.80674061 |
| 137 | Loss of speech (HP:0002371) | 1.80265704 |
| 138 | Bone pain (HP:0002653) | 1.79872418 |
| 139 | Abnormality of the Achilles tendon (HP:0005109) | 1.79766201 |
| 140 | Craniofacial dystonia (HP:0012179) | 1.78773745 |
| 141 | Insomnia (HP:0100785) | 1.78614488 |
| 142 | Blue irides (HP:0000635) | 1.78206724 |
| 143 | Fetal akinesia sequence (HP:0001989) | 1.77996391 |
| 144 | Apathy (HP:0000741) | 1.77180933 |
| 145 | Increased circulating renin level (HP:0000848) | 1.76637513 |
| 146 | Peripheral hypomyelination (HP:0007182) | 1.76394730 |
| 147 | Lower limb muscle weakness (HP:0007340) | 1.76156121 |
| 148 | Urinary urgency (HP:0000012) | 1.73697460 |
| 149 | Long toe (HP:0010511) | 1.70414062 |
| 150 | Obstructive lung disease (HP:0006536) | 1.69983975 |
| 151 | Chronic obstructive pulmonary disease (HP:0006510) | 1.69983975 |
| 152 | Thoracic kyphosis (HP:0002942) | 1.68576806 |
| 153 | Abnormal neuron morphology (HP:0012757) | 1.67444225 |
| 154 | Abnormality of the motor neurons (HP:0002450) | 1.67444225 |
| 155 | Petechiae (HP:0000967) | 1.65995357 |
| 156 | Abnormality of the nasal mucosa (HP:0000433) | 1.65913610 |
| 157 | Reticulocytosis (HP:0001923) | 1.65576327 |
| 158 | Premature rupture of membranes (HP:0001788) | 1.64803931 |
| 159 | Joint stiffness (HP:0001387) | 1.64015017 |
| 160 | Urinary incontinence (HP:0000020) | 1.63296137 |
| 161 | Broad face (HP:0000283) | 1.62918438 |
| 162 | Hypertensive crisis (HP:0100735) | 1.60472305 |
| 163 | Slow saccadic eye movements (HP:0000514) | 1.60123570 |
| 164 | Stridor (HP:0010307) | 1.59192660 |
| 165 | Athetosis (HP:0002305) | 1.57980884 |
| 166 | Distal lower limb amyotrophy (HP:0008944) | 1.57587456 |
| 167 | Mitral stenosis (HP:0001718) | 1.57104135 |
| 168 | Abdominal distention (HP:0003270) | 1.56356415 |
| 169 | Fasciculations (HP:0002380) | 1.56348768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.69780336 |
| 2 | NTRK3 | 3.57387100 |
| 3 | CASK | 3.45103565 |
| 4 | TESK1 | 3.38603640 |
| 5 | MAP3K9 | 3.04560082 |
| 6 | TESK2 | 3.04484587 |
| 7 | IRAK3 | 2.94687661 |
| 8 | ERN1 | 2.92496119 |
| 9 | MAP3K12 | 2.71234932 |
| 10 | NME2 | 2.67489211 |
| 11 | EPHA4 | 2.67424204 |
| 12 | MAP3K4 | 2.49952150 |
| 13 | MAP2K7 | 2.28850481 |
| 14 | MAP3K11 | 2.25662953 |
| 15 | DAPK2 | 2.23440388 |
| 16 | NTRK1 | 2.16991814 |
| 17 | CDK19 | 2.16247457 |
| 18 | SIK1 | 2.16069540 |
| 19 | PLK2 | 2.13233650 |
| 20 | OXSR1 | 2.11139077 |
| 21 | MINK1 | 2.09960541 |
| 22 | RIPK4 | 2.04031704 |
| 23 | MARK1 | 1.97463290 |
| 24 | PIM2 | 1.91235469 |
| 25 | CAMKK2 | 1.83990222 |
| 26 | ICK | 1.82668270 |
| 27 | SMG1 | 1.76997456 |
| 28 | RIPK1 | 1.76151962 |
| 29 | TAOK2 | 1.71800015 |
| 30 | PAK6 | 1.71641084 |
| 31 | KSR2 | 1.71604271 |
| 32 | PRPF4B | 1.66869764 |
| 33 | GRK5 | 1.61808321 |
| 34 | PKN2 | 1.61343282 |
| 35 | MAP2K4 | 1.60640393 |
| 36 | TAOK1 | 1.56881643 |
| 37 | ARAF | 1.54061108 |
| 38 | DAPK1 | 1.51552694 |
| 39 | MAP3K2 | 1.45568067 |
| 40 | EPHA2 | 1.44335032 |
| 41 | TBK1 | 1.43408346 |
| 42 | MAP3K3 | 1.41298081 |
| 43 | CDK5 | 1.41255118 |
| 44 | CAMKK1 | 1.35300923 |
| 45 | NTRK2 | 1.34229545 |
| 46 | FES | 1.34065590 |
| 47 | BCKDK | 1.26991553 |
| 48 | PRKCG | 1.19923970 |
| 49 | PRKCH | 1.18840864 |
| 50 | SGK494 | 1.16571976 |
| 51 | SGK223 | 1.16571976 |
| 52 | CAMK2A | 1.10494073 |
| 53 | CAMK2B | 1.10226872 |
| 54 | PTK2B | 1.04261222 |
| 55 | EPHB1 | 1.03336734 |
| 56 | PAK4 | 1.01131810 |
| 57 | STK39 | 1.00714569 |
| 58 | PRKCE | 0.99230776 |
| 59 | PHKG1 | 0.97139459 |
| 60 | PHKG2 | 0.97139459 |
| 61 | MAPKAPK3 | 0.96477496 |
| 62 | MAP3K13 | 0.96022722 |
| 63 | MAP2K3 | 0.94800634 |
| 64 | PAK3 | 0.94327121 |
| 65 | WNK4 | 0.94085674 |
| 66 | PRKD3 | 0.93855618 |
| 67 | AKT3 | 0.93517287 |
| 68 | BLK | 0.92699185 |
| 69 | UHMK1 | 0.91758108 |
| 70 | FGFR4 | 0.90163529 |
| 71 | MARK2 | 0.89999523 |
| 72 | CDK14 | 0.89646246 |
| 73 | TYK2 | 0.87406304 |
| 74 | CCNB1 | 0.84773412 |
| 75 | KSR1 | 0.83401223 |
| 76 | GRK7 | 0.83290323 |
| 77 | CDK18 | 0.83154373 |
| 78 | FGR | 0.83034486 |
| 79 | CAMK2D | 0.82548003 |
| 80 | CDC42BPA | 0.82200905 |
| 81 | LIMK1 | 0.81108066 |
| 82 | CDK15 | 0.79873126 |
| 83 | MATK | 0.79739643 |
| 84 | ABL2 | 0.79246079 |
| 85 | MAP3K1 | 0.79137514 |
| 86 | RET | 0.77502025 |
| 87 | EEF2K | 0.77112388 |
| 88 | PRKD2 | 0.76226800 |
| 89 | PDK2 | 0.75524490 |
| 90 | INSRR | 0.75412350 |
| 91 | MAPK13 | 0.74925350 |
| 92 | FER | 0.74680345 |
| 93 | GRK6 | 0.74493415 |
| 94 | SCYL2 | 0.73670638 |
| 95 | IRAK4 | 0.73126170 |
| 96 | MAPKAPK5 | 0.72967613 |
| 97 | TNIK | 0.72953284 |
| 98 | PDPK1 | 0.70814308 |
| 99 | IRAK2 | 0.70238166 |
| 100 | WNK3 | 0.69900089 |
| 101 | PDK3 | 0.69564883 |
| 102 | PDK4 | 0.69564883 |
| 103 | SGK2 | 0.68865481 |
| 104 | CSNK1G2 | 0.68318399 |
| 105 | MAP2K1 | 0.66033175 |
| 106 | WNK1 | 0.65414701 |
| 107 | MAP3K14 | 0.64758462 |
| 108 | CDK11A | 0.64268674 |
| 109 | CAMK2G | 0.64019855 |
| 110 | DYRK1B | 0.63909268 |
| 111 | PTK6 | 0.63162268 |
| 112 | TGFBR2 | 0.61884370 |
| 113 | DAPK3 | 0.61741926 |
| 114 | ZAP70 | 0.61689066 |
| 115 | BCR | 0.61528800 |
| 116 | SIK3 | 0.61501905 |
| 117 | FYN | 0.59745359 |
| 118 | PDK1 | 0.58546960 |
| 119 | SGK3 | 0.58308806 |
| 120 | MAP2K2 | 0.58031149 |
| 121 | ROCK2 | 0.57178894 |
| 122 | BMPR2 | 0.57013702 |
| 123 | TSSK6 | 0.56025917 |
| 124 | TTN | 0.55840613 |
| 125 | CSK | 0.55554245 |
| 126 | BMPR1B | 0.55276051 |
| 127 | TNK2 | 0.55038925 |
| 128 | SIK2 | 0.54599468 |
| 129 | CSF1R | 0.54142820 |
| 130 | ADRBK1 | 0.53757821 |
| 131 | NME1 | 0.53622472 |
| 132 | EPHA3 | 0.52146064 |
| 133 | SGK1 | 0.51200177 |
| 134 | CAMK1D | 0.50470152 |
| 135 | CAMK1 | 0.50406395 |
| 136 | PDGFRA | 0.49062945 |
| 137 | CSNK1G3 | 0.48450151 |
| 138 | PTK2 | 0.47698698 |
| 139 | MYLK | 0.47527928 |
| 140 | LRRK2 | 0.47003923 |
| 141 | RPS6KC1 | 0.46921034 |
| 142 | RPS6KL1 | 0.46921034 |
| 143 | ADRBK2 | 0.46825434 |
| 144 | MAPK12 | 0.46693125 |
| 145 | STK38 | 0.46674229 |
| 146 | PRKG2 | 0.46290840 |
| 147 | MAP3K6 | 0.43732500 |
| 148 | KDR | 0.43229264 |
| 149 | PRKD1 | 0.43140648 |
| 150 | RPS6KA2 | 0.42888552 |
| 151 | TYRO3 | 0.42580604 |
| 152 | STK11 | 0.42502136 |
| 153 | HIPK2 | 0.42228187 |
| 154 | LATS2 | 0.42190297 |
| 155 | PKN1 | 0.42055747 |
| 156 | DYRK1A | 0.41204058 |
| 157 | MOS | 0.39214174 |
| 158 | DDR2 | 0.35817383 |
| 159 | CAMK1G | 0.35245748 |
| 160 | LMTK2 | 0.35206546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.78217663 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.34558151 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.90788899 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.83623606 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.33543731 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.28101767 |
| 7 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.25048814 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.09998084 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.08513586 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.07614637 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91752052 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.87581989 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.83853839 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.83435582 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.82491675 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77290127 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.68830986 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.64810445 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53130296 |
| 20 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.51402401 |
| 21 | * Lysosome_Homo sapiens_hsa04142 | 1.51023224 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.50433144 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48811496 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.48792649 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.45314358 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.44945536 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.44209799 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.41975860 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41890503 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40626722 |
| 31 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32966701 |
| 32 | * Phagosome_Homo sapiens_hsa04145 | 1.31919584 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31658091 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30491773 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27274695 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27005378 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26980578 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20449837 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.20089841 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.19968250 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17199927 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15895402 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.14061162 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.11759058 |
| 45 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11429274 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08341856 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07159420 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06300855 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04043340 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00239784 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00067032 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99473205 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.98955879 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 0.98578857 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96592747 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95082786 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94926513 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93054272 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.91384749 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90253930 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87786227 |
| 62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86772331 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86673791 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85961362 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84226734 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83800799 |
| 67 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83311353 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83098413 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82421064 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.80956092 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80795643 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.80794549 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 0.77657585 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.77593795 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76925088 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76360137 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74970362 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74823012 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74541778 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.73835231 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73177851 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72823211 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71350407 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70673046 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70293836 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68590139 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66471263 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66366230 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.65881817 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63940228 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63481761 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63232395 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63050238 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62700200 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61918647 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.61688627 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61473517 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61273637 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60728473 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60046752 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58805669 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58672881 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58364957 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57572859 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57482928 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56014595 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.55958606 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54986942 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54873777 |
| 110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54745339 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53705837 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.53504169 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52302266 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52223729 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.51885848 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51318241 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51263327 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50740612 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.50417914 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49296155 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48755302 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48055837 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46805686 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46332496 |
| 125 | * Tuberculosis_Homo sapiens_hsa05152 | 0.45114760 |
| 126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43429208 |
| 127 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41628195 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.41004315 |
| 129 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39943553 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39244186 |
| 131 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39228604 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39079352 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38342050 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38298697 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37656152 |
| 136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35886727 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35526802 |
| 138 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35458573 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35401021 |
| 140 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35019175 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34673531 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33926774 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33274856 |
| 144 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32631821 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31944082 |
| 146 | Mineral absorption_Homo sapiens_hsa04978 | 0.31572152 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29634158 |
| 148 | Salmonella infection_Homo sapiens_hsa05132 | 0.29603648 |
| 149 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29314278 |
| 150 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27425160 |

